chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, Metabolic function test normal, Mitral valve incompetence, Pleural effusion, Pyrexia
Clinical narrative: Patient is a 58 y.o. female patient of, MD with history of cardiomyopathy, CKD stage IV, anemia, HTN, CVA, and hypercholesterolemia presented to Hospital with shortness of breath.   Acute hypoxic respiratory failure Covid-19 Virus Infection P/w SOB, SpO2 83% per EMS requiring 3L NC Date of onset of symptoms: 2 days prior to admission Symptoms present on admission: fever, shortness of breath, nonproductive cough Date of covid positive test: 2/9/23 Vaccination status: vaccinated x3 (last in Dec 2021) Imaging: CXR shows patchy multifocal opacities, cardiomegaly, and small left pleural effusion Oxygen requirements on admission: 3L Current oxygen requirements: RA Medical therapy: steroids. Unable to use Remdesivir due to CKD Consultants following: None Anticipated special isolation end date: tentatively 2/19      Hypoxia completely resolved, currently on room air, did not qualify for home O2.  We will continue 10 days of dexamethasone after discharge.   Chronic HFrEF Echo with EF 40-45%, mild-mod MR.  She has no evidence of decompensation Cardiology was consulted and signed off now Continue home medications Due to AKI, I will liberalize her fluid intake Hold diuretics for next 24 hours    Elevated Troponin  In the setting of chronic kidney disease Troponin is down trending, no history of chest pain Echo stable from previous imaging Cardiology evaluated and signed off  Hyperglycemia without Dx of DM BG 192 on BMP
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin
Clinical narrative: Patient is a 58 y.o. female patient of, MD with history of cardiomyopathy, CKD stage IV, anemia, HTN, CVA, and hypercholesterolemia presented to Hospital with shortness of breath.   Acute hypoxic respiratory failure Covid-19 Virus Infection P/w SOB, SpO2 83% per EMS requiring 3L NC Date of onset of symptoms: 2 days prior to admission Symptoms present on admission: fever, shortness of breath, nonproductive cough Date of covid positive test: 2/9/23 Vaccination status: vaccinated x3 (last in Dec 2021) Imaging: CXR shows patchy multifocal opacities, cardiomegaly, and small left pleural effusion Oxygen requirements on admission: 3L Current oxygen requirements: RA Medical therapy: steroids. Unable to use Remdesivir due to CKD Consultants following: None Anticipated special isolation end date: tentatively 2/19      Hypoxia completely resolved, currently on room air, did not qualify for home O2.  We will continue 10 days of dexamethasone after discharge.   Chronic HFrEF Echo with EF 40-45%, mild-mod MR.  She has no evidence of decompensation Cardiology was consulted and signed off now Continue home medications Due to AKI, I will liberalize her fluid intake Hold diuretics for next 24 hours    Elevated Troponin  In the setting of chronic kidney disease Troponin is down trending, no history of chest pain Echo stable from previous imaging Cardiology evaluated and signed off  Hyperglycemia without Dx of DM BG 192 on BMP
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Injection site red, swollen, minor pain
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blister, Herpes zoster, Neuralgia, Rash, Scab
Clinical narrative: The dermatome was first noticeable on February 1st and breakout on February 9th, followed where pain on sciatic nerve began. It went down the inner part of my left thigh and a big patch of blisters behind and next to my knee. I saw a nurse at a local clinic, I explained and showed her the blisters and she confirmed that it was shingles. I was prescribed an antiviral and I ordered something offline called shingles that I currently use because it hasn't completely gone away. It goes from blisters to scabs.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sciatica
Clinical narrative: The dermatome was first noticeable on February 1st and breakout on February 9th, followed where pain on sciatic nerve began. It went down the inner part of my left thigh and a big patch of blisters behind and next to my knee. I saw a nurse at a local clinic, I explained and showed her the blisters and she confirmed that it was shingles. I was prescribed an antiviral and I ordered something offline called shingles that I currently use because it hasn't completely gone away. It goes from blisters to scabs.
Age: 2.0
Sex: M
Vaccine: FLU4, MMR, PNC13, TD
Symptoms: Wrong product administered
Clinical narrative: A Tetanus and Diptheria vaccine was given instead of a Vaxelius.
Age: 11.0
Sex: M
Vaccine: HPV9, MENB
Symptoms: Cellulitis, Erythema, Feeling hot, Peripheral swelling, Wrong product administered
Clinical narrative: Patient was in office and due for Menveo vaccine, MA gave Men B in error. Patient presented in urgent care 3/2/2023 with redness, warmth, and swelling of right arm and was diagnosed with cellulitis and given a script for cephalexin. 3/7/2023 patient presented to PCP for follow up and symptoms have resolved.
Age: 82.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: +COVID-vaccinated
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 1/28/21 Lot# 007M20A;  Moderna 4/8/21 Lot# 018B21A;  Moderna 12/14/21 Lot# 029H21B
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Nausea
Clinical narrative: Patient came to the ED with generalized weakness and nausea.  Patient admitted to the hospital with Covid and treated with remdesivir.
Age: 80.0
Sex: U
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Got Covid, was vaccinated
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal mass, Abdominal pain, Ascites, Bacteraemia, Blood bilirubin normal
Clinical narrative: Patient is a 46 y.o. female with a history of ESRD on Dialysis, GPA,  chronic respiratory failure, admission to hospital (1/11-12/23) for fever, respiratory failure, volume overload as well as AMS, left AMA, repeat ED visit 2/6/23 for nausea/dizzness, left AMA who presented to hospital 2/10/2023 with COVID+, shortness of breath, nausea, generalized pain. CXR with pulmonary venous congestion and R sided Effusion. NT-proBNP of 154k, Troponin 253. CBC with pancytopenia.    1. COVID19 with Chronic Respiratory Failure: reported positive on 2/8/23 at Hospital., with pancytopenia On 6L NC at baseline per patient, continued. On paxlovid PTA. CXR as above.  Goal sp02 88-92%. Initiated steroids (2/10-20/23) given risk factors, will send home with prescription. 2. Elevated Troponin: 253 on admission, repeat of 233, hx of elevated troponin. Possibly Type 2 in the setting of demand, fluid overload, ESRD. EKG with NSR. TTE 1/2023 with EF 50-55%, pHTN. Repeat TTE pending, pt would like to follow up with the results at OP follow up. 3. Acute on Chronic HFrecEF/Pulm HTN: per hx, TTE as noted above. NT-proBNP of 154k, mild fluid overload. Symptoms much improved after Dialysis on 2/10-11.  4. Abdominal Pain: reported acute on chronic, diffuse without guarding. Suspect in the setting of COVID19, however hx of diverticulitis 12/2022. CT A/P 1/2023 at Hospital reported improvement in colitis, abdominal omental nodules. Admit CT A/P showed stable hepatic cyst, CBD measuring 12mm (thought to be dt reservoir following cholecystectomy, small volume ascites. LFTs unremarkable including normal bili. Symptoms much improved after Dialysis on 2/10-11.  5. Epistaxis: in the setting of COVID19, thrombocytopenia, as well as chronic 02. Humidify 02. Resolved in ED.  6. Hypocalcemia: hx of. ical of 3.6, repleted.  7. ESRD On Dialysis: per hx MWF Dialysis in the setting of GPA. Recent Dialysis catheter infection with exchange 10/2022 due to proteus bacteremia. Undergoing transplant evaluation at Hospital. Nephrology followed, Dialysis ran 2/10, 2/11.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure, Cardiac failure acute, Chest X-ray abnormal, Cholecystectomy
Clinical narrative: Patient is a 46 y.o. female with a history of ESRD on Dialysis, GPA,  chronic respiratory failure, admission to hospital (1/11-12/23) for fever, respiratory failure, volume overload as well as AMS, left AMA, repeat ED visit 2/6/23 for nausea/dizzness, left AMA who presented to hospital 2/10/2023 with COVID+, shortness of breath, nausea, generalized pain. CXR with pulmonary venous congestion and R sided Effusion. NT-proBNP of 154k, Troponin 253. CBC with pancytopenia.    1. COVID19 with Chronic Respiratory Failure: reported positive on 2/8/23 at Hospital., with pancytopenia On 6L NC at baseline per patient, continued. On paxlovid PTA. CXR as above.  Goal sp02 88-92%. Initiated steroids (2/10-20/23) given risk factors, will send home with prescription. 2. Elevated Troponin: 253 on admission, repeat of 233, hx of elevated troponin. Possibly Type 2 in the setting of demand, fluid overload, ESRD. EKG with NSR. TTE 1/2023 with EF 50-55%, pHTN. Repeat TTE pending, pt would like to follow up with the results at OP follow up. 3. Acute on Chronic HFrecEF/Pulm HTN: per hx, TTE as noted above. NT-proBNP of 154k, mild fluid overload. Symptoms much improved after Dialysis on 2/10-11.  4. Abdominal Pain: reported acute on chronic, diffuse without guarding. Suspect in the setting of COVID19, however hx of diverticulitis 12/2022. CT A/P 1/2023 at Hospital reported improvement in colitis, abdominal omental nodules. Admit CT A/P showed stable hepatic cyst, CBD measuring 12mm (thought to be dt reservoir following cholecystectomy, small volume ascites. LFTs unremarkable including normal bili. Symptoms much improved after Dialysis on 2/10-11.  5. Epistaxis: in the setting of COVID19, thrombocytopenia, as well as chronic 02. Humidify 02. Resolved in ED.  6. Hypocalcemia: hx of. ical of 3.6, repleted.  7. ESRD On Dialysis: per hx MWF Dialysis in the setting of GPA. Recent Dialysis catheter infection with exchange 10/2022 due to proteus bacteremia. Undergoing transplant evaluation at Hospital. Nephrology followed, Dialysis ran 2/10, 2/11.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Colitis, Computerised tomogram abdomen abnormal, Condition aggravated, Device related infection
Clinical narrative: Patient is a 46 y.o. female with a history of ESRD on Dialysis, GPA,  chronic respiratory failure, admission to hospital (1/11-12/23) for fever, respiratory failure, volume overload as well as AMS, left AMA, repeat ED visit 2/6/23 for nausea/dizzness, left AMA who presented to hospital 2/10/2023 with COVID+, shortness of breath, nausea, generalized pain. CXR with pulmonary venous congestion and R sided Effusion. NT-proBNP of 154k, Troponin 253. CBC with pancytopenia.    1. COVID19 with Chronic Respiratory Failure: reported positive on 2/8/23 at Hospital., with pancytopenia On 6L NC at baseline per patient, continued. On paxlovid PTA. CXR as above.  Goal sp02 88-92%. Initiated steroids (2/10-20/23) given risk factors, will send home with prescription. 2. Elevated Troponin: 253 on admission, repeat of 233, hx of elevated troponin. Possibly Type 2 in the setting of demand, fluid overload, ESRD. EKG with NSR. TTE 1/2023 with EF 50-55%, pHTN. Repeat TTE pending, pt would like to follow up with the results at OP follow up. 3. Acute on Chronic HFrecEF/Pulm HTN: per hx, TTE as noted above. NT-proBNP of 154k, mild fluid overload. Symptoms much improved after Dialysis on 2/10-11.  4. Abdominal Pain: reported acute on chronic, diffuse without guarding. Suspect in the setting of COVID19, however hx of diverticulitis 12/2022. CT A/P 1/2023 at Hospital reported improvement in colitis, abdominal omental nodules. Admit CT A/P showed stable hepatic cyst, CBD measuring 12mm (thought to be dt reservoir following cholecystectomy, small volume ascites. LFTs unremarkable including normal bili. Symptoms much improved after Dialysis on 2/10-11.  5. Epistaxis: in the setting of COVID19, thrombocytopenia, as well as chronic 02. Humidify 02. Resolved in ED.  6. Hypocalcemia: hx of. ical of 3.6, repleted.  7. ESRD On Dialysis: per hx MWF Dialysis in the setting of GPA. Recent Dialysis catheter infection with exchange 10/2022 due to proteus bacteremia. Undergoing transplant evaluation at Hospital. Nephrology followed, Dialysis ran 2/10, 2/11.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Diverticulitis, Dizziness, Dyspnoea, Echocardiogram, Ejection fraction normal
Clinical narrative: Patient is a 46 y.o. female with a history of ESRD on Dialysis, GPA,  chronic respiratory failure, admission to hospital (1/11-12/23) for fever, respiratory failure, volume overload as well as AMS, left AMA, repeat ED visit 2/6/23 for nausea/dizzness, left AMA who presented to hospital 2/10/2023 with COVID+, shortness of breath, nausea, generalized pain. CXR with pulmonary venous congestion and R sided Effusion. NT-proBNP of 154k, Troponin 253. CBC with pancytopenia.    1. COVID19 with Chronic Respiratory Failure: reported positive on 2/8/23 at Hospital., with pancytopenia On 6L NC at baseline per patient, continued. On paxlovid PTA. CXR as above.  Goal sp02 88-92%. Initiated steroids (2/10-20/23) given risk factors, will send home with prescription. 2. Elevated Troponin: 253 on admission, repeat of 233, hx of elevated troponin. Possibly Type 2 in the setting of demand, fluid overload, ESRD. EKG with NSR. TTE 1/2023 with EF 50-55%, pHTN. Repeat TTE pending, pt would like to follow up with the results at OP follow up. 3. Acute on Chronic HFrecEF/Pulm HTN: per hx, TTE as noted above. NT-proBNP of 154k, mild fluid overload. Symptoms much improved after Dialysis on 2/10-11.  4. Abdominal Pain: reported acute on chronic, diffuse without guarding. Suspect in the setting of COVID19, however hx of diverticulitis 12/2022. CT A/P 1/2023 at Hospital reported improvement in colitis, abdominal omental nodules. Admit CT A/P showed stable hepatic cyst, CBD measuring 12mm (thought to be dt reservoir following cholecystectomy, small volume ascites. LFTs unremarkable including normal bili. Symptoms much improved after Dialysis on 2/10-11.  5. Epistaxis: in the setting of COVID19, thrombocytopenia, as well as chronic 02. Humidify 02. Resolved in ED.  6. Hypocalcemia: hx of. ical of 3.6, repleted.  7. ESRD On Dialysis: per hx MWF Dialysis in the setting of GPA. Recent Dialysis catheter infection with exchange 10/2022 due to proteus bacteremia. Undergoing transplant evaluation at Hospital. Nephrology followed, Dialysis ran 2/10, 2/11.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Epistaxis, Full blood count abnormal, Haemodialysis, Hepatic cyst
Clinical narrative: Patient is a 46 y.o. female with a history of ESRD on Dialysis, GPA,  chronic respiratory failure, admission to hospital (1/11-12/23) for fever, respiratory failure, volume overload as well as AMS, left AMA, repeat ED visit 2/6/23 for nausea/dizzness, left AMA who presented to hospital 2/10/2023 with COVID+, shortness of breath, nausea, generalized pain. CXR with pulmonary venous congestion and R sided Effusion. NT-proBNP of 154k, Troponin 253. CBC with pancytopenia.    1. COVID19 with Chronic Respiratory Failure: reported positive on 2/8/23 at Hospital., with pancytopenia On 6L NC at baseline per patient, continued. On paxlovid PTA. CXR as above.  Goal sp02 88-92%. Initiated steroids (2/10-20/23) given risk factors, will send home with prescription. 2. Elevated Troponin: 253 on admission, repeat of 233, hx of elevated troponin. Possibly Type 2 in the setting of demand, fluid overload, ESRD. EKG with NSR. TTE 1/2023 with EF 50-55%, pHTN. Repeat TTE pending, pt would like to follow up with the results at OP follow up. 3. Acute on Chronic HFrecEF/Pulm HTN: per hx, TTE as noted above. NT-proBNP of 154k, mild fluid overload. Symptoms much improved after Dialysis on 2/10-11.  4. Abdominal Pain: reported acute on chronic, diffuse without guarding. Suspect in the setting of COVID19, however hx of diverticulitis 12/2022. CT A/P 1/2023 at Hospital reported improvement in colitis, abdominal omental nodules. Admit CT A/P showed stable hepatic cyst, CBD measuring 12mm (thought to be dt reservoir following cholecystectomy, small volume ascites. LFTs unremarkable including normal bili. Symptoms much improved after Dialysis on 2/10-11.  5. Epistaxis: in the setting of COVID19, thrombocytopenia, as well as chronic 02. Humidify 02. Resolved in ED.  6. Hypocalcemia: hx of. ical of 3.6, repleted.  7. ESRD On Dialysis: per hx MWF Dialysis in the setting of GPA. Recent Dialysis catheter infection with exchange 10/2022 due to proteus bacteremia. Undergoing transplant evaluation at Hospital. Nephrology followed, Dialysis ran 2/10, 2/11.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hypervolaemia, Hypocalcaemia, Liver function test normal, Mental status changes, N-terminal prohormone brain natriuretic peptide increased
Clinical narrative: Patient is a 46 y.o. female with a history of ESRD on Dialysis, GPA,  chronic respiratory failure, admission to hospital (1/11-12/23) for fever, respiratory failure, volume overload as well as AMS, left AMA, repeat ED visit 2/6/23 for nausea/dizzness, left AMA who presented to hospital 2/10/2023 with COVID+, shortness of breath, nausea, generalized pain. CXR with pulmonary venous congestion and R sided Effusion. NT-proBNP of 154k, Troponin 253. CBC with pancytopenia.    1. COVID19 with Chronic Respiratory Failure: reported positive on 2/8/23 at Hospital., with pancytopenia On 6L NC at baseline per patient, continued. On paxlovid PTA. CXR as above.  Goal sp02 88-92%. Initiated steroids (2/10-20/23) given risk factors, will send home with prescription. 2. Elevated Troponin: 253 on admission, repeat of 233, hx of elevated troponin. Possibly Type 2 in the setting of demand, fluid overload, ESRD. EKG with NSR. TTE 1/2023 with EF 50-55%, pHTN. Repeat TTE pending, pt would like to follow up with the results at OP follow up. 3. Acute on Chronic HFrecEF/Pulm HTN: per hx, TTE as noted above. NT-proBNP of 154k, mild fluid overload. Symptoms much improved after Dialysis on 2/10-11.  4. Abdominal Pain: reported acute on chronic, diffuse without guarding. Suspect in the setting of COVID19, however hx of diverticulitis 12/2022. CT A/P 1/2023 at Hospital reported improvement in colitis, abdominal omental nodules. Admit CT A/P showed stable hepatic cyst, CBD measuring 12mm (thought to be dt reservoir following cholecystectomy, small volume ascites. LFTs unremarkable including normal bili. Symptoms much improved after Dialysis on 2/10-11.  5. Epistaxis: in the setting of COVID19, thrombocytopenia, as well as chronic 02. Humidify 02. Resolved in ED.  6. Hypocalcemia: hx of. ical of 3.6, repleted.  7. ESRD On Dialysis: per hx MWF Dialysis in the setting of GPA. Recent Dialysis catheter infection with exchange 10/2022 due to proteus bacteremia. Undergoing transplant evaluation at Hospital. Nephrology followed, Dialysis ran 2/10, 2/11.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pancytopenia, Pleural effusion, Proteus infection
Clinical narrative: Patient is a 46 y.o. female with a history of ESRD on Dialysis, GPA,  chronic respiratory failure, admission to hospital (1/11-12/23) for fever, respiratory failure, volume overload as well as AMS, left AMA, repeat ED visit 2/6/23 for nausea/dizzness, left AMA who presented to hospital 2/10/2023 with COVID+, shortness of breath, nausea, generalized pain. CXR with pulmonary venous congestion and R sided Effusion. NT-proBNP of 154k, Troponin 253. CBC with pancytopenia.    1. COVID19 with Chronic Respiratory Failure: reported positive on 2/8/23 at Hospital., with pancytopenia On 6L NC at baseline per patient, continued. On paxlovid PTA. CXR as above.  Goal sp02 88-92%. Initiated steroids (2/10-20/23) given risk factors, will send home with prescription. 2. Elevated Troponin: 253 on admission, repeat of 233, hx of elevated troponin. Possibly Type 2 in the setting of demand, fluid overload, ESRD. EKG with NSR. TTE 1/2023 with EF 50-55%, pHTN. Repeat TTE pending, pt would like to follow up with the results at OP follow up. 3. Acute on Chronic HFrecEF/Pulm HTN: per hx, TTE as noted above. NT-proBNP of 154k, mild fluid overload. Symptoms much improved after Dialysis on 2/10-11.  4. Abdominal Pain: reported acute on chronic, diffuse without guarding. Suspect in the setting of COVID19, however hx of diverticulitis 12/2022. CT A/P 1/2023 at Hospital reported improvement in colitis, abdominal omental nodules. Admit CT A/P showed stable hepatic cyst, CBD measuring 12mm (thought to be dt reservoir following cholecystectomy, small volume ascites. LFTs unremarkable including normal bili. Symptoms much improved after Dialysis on 2/10-11.  5. Epistaxis: in the setting of COVID19, thrombocytopenia, as well as chronic 02. Humidify 02. Resolved in ED.  6. Hypocalcemia: hx of. ical of 3.6, repleted.  7. ESRD On Dialysis: per hx MWF Dialysis in the setting of GPA. Recent Dialysis catheter infection with exchange 10/2022 due to proteus bacteremia. Undergoing transplant evaluation at Hospital. Nephrology followed, Dialysis ran 2/10, 2/11.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary congestion, Pulmonary hypertension, Pyrexia, SARS-CoV-2 test positive, Thrombocytopenia
Clinical narrative: Patient is a 46 y.o. female with a history of ESRD on Dialysis, GPA,  chronic respiratory failure, admission to hospital (1/11-12/23) for fever, respiratory failure, volume overload as well as AMS, left AMA, repeat ED visit 2/6/23 for nausea/dizzness, left AMA who presented to hospital 2/10/2023 with COVID+, shortness of breath, nausea, generalized pain. CXR with pulmonary venous congestion and R sided Effusion. NT-proBNP of 154k, Troponin 253. CBC with pancytopenia.    1. COVID19 with Chronic Respiratory Failure: reported positive on 2/8/23 at Hospital., with pancytopenia On 6L NC at baseline per patient, continued. On paxlovid PTA. CXR as above.  Goal sp02 88-92%. Initiated steroids (2/10-20/23) given risk factors, will send home with prescription. 2. Elevated Troponin: 253 on admission, repeat of 233, hx of elevated troponin. Possibly Type 2 in the setting of demand, fluid overload, ESRD. EKG with NSR. TTE 1/2023 with EF 50-55%, pHTN. Repeat TTE pending, pt would like to follow up with the results at OP follow up. 3. Acute on Chronic HFrecEF/Pulm HTN: per hx, TTE as noted above. NT-proBNP of 154k, mild fluid overload. Symptoms much improved after Dialysis on 2/10-11.  4. Abdominal Pain: reported acute on chronic, diffuse without guarding. Suspect in the setting of COVID19, however hx of diverticulitis 12/2022. CT A/P 1/2023 at Hospital reported improvement in colitis, abdominal omental nodules. Admit CT A/P showed stable hepatic cyst, CBD measuring 12mm (thought to be dt reservoir following cholecystectomy, small volume ascites. LFTs unremarkable including normal bili. Symptoms much improved after Dialysis on 2/10-11.  5. Epistaxis: in the setting of COVID19, thrombocytopenia, as well as chronic 02. Humidify 02. Resolved in ED.  6. Hypocalcemia: hx of. ical of 3.6, repleted.  7. ESRD On Dialysis: per hx MWF Dialysis in the setting of GPA. Recent Dialysis catheter infection with exchange 10/2022 due to proteus bacteremia. Undergoing transplant evaluation at Hospital. Nephrology followed, Dialysis ran 2/10, 2/11.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: Patient is a 46 y.o. female with a history of ESRD on Dialysis, GPA,  chronic respiratory failure, admission to hospital (1/11-12/23) for fever, respiratory failure, volume overload as well as AMS, left AMA, repeat ED visit 2/6/23 for nausea/dizzness, left AMA who presented to hospital 2/10/2023 with COVID+, shortness of breath, nausea, generalized pain. CXR with pulmonary venous congestion and R sided Effusion. NT-proBNP of 154k, Troponin 253. CBC with pancytopenia.    1. COVID19 with Chronic Respiratory Failure: reported positive on 2/8/23 at Hospital., with pancytopenia On 6L NC at baseline per patient, continued. On paxlovid PTA. CXR as above.  Goal sp02 88-92%. Initiated steroids (2/10-20/23) given risk factors, will send home with prescription. 2. Elevated Troponin: 253 on admission, repeat of 233, hx of elevated troponin. Possibly Type 2 in the setting of demand, fluid overload, ESRD. EKG with NSR. TTE 1/2023 with EF 50-55%, pHTN. Repeat TTE pending, pt would like to follow up with the results at OP follow up. 3. Acute on Chronic HFrecEF/Pulm HTN: per hx, TTE as noted above. NT-proBNP of 154k, mild fluid overload. Symptoms much improved after Dialysis on 2/10-11.  4. Abdominal Pain: reported acute on chronic, diffuse without guarding. Suspect in the setting of COVID19, however hx of diverticulitis 12/2022. CT A/P 1/2023 at Hospital reported improvement in colitis, abdominal omental nodules. Admit CT A/P showed stable hepatic cyst, CBD measuring 12mm (thought to be dt reservoir following cholecystectomy, small volume ascites. LFTs unremarkable including normal bili. Symptoms much improved after Dialysis on 2/10-11.  5. Epistaxis: in the setting of COVID19, thrombocytopenia, as well as chronic 02. Humidify 02. Resolved in ED.  6. Hypocalcemia: hx of. ical of 3.6, repleted.  7. ESRD On Dialysis: per hx MWF Dialysis in the setting of GPA. Recent Dialysis catheter infection with exchange 10/2022 due to proteus bacteremia. Undergoing transplant evaluation at Hospital. Nephrology followed, Dialysis ran 2/10, 2/11.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 1/28/21 Lot# 007M20A;  Moderna 4/8/21 Lot# 018B21A;  Moderna 12/14/21 Lot# 029H21B
Age: 65.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Got COVID, was vaccinated
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 3/12/21 Lot# EN6206;  Pfizer 4/5/21 Lot# Ew0150;  Pfizer 10/21/21 Lot# 32030BD
Age: 29.0
Sex: M
Vaccine: TDAP
Symptoms: Back pain, Flank pain, Lymphadenopathy, Neck pain, Pain in extremity
Clinical narrative: The pt is experiencing fever, a sore and achy arm from the elbow upward, pain in the side and back (also experienced with COVID vaccine), swollen lymph node and neck pain.
Age: 29.0
Sex: M
Vaccine: TDAP
Symptoms: Pyrexia
Clinical narrative: The pt is experiencing fever, a sore and achy arm from the elbow upward, pain in the side and back (also experienced with COVID vaccine), swollen lymph node and neck pain.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 10/13/21 Lot# FF2589;  Pfizer 11/3/21 Lot# FG3527
Age: 46.0
Sex: M
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Got Covid, was vax'd
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Back pain, Chills, Headache, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Sick with back pain, headache, chills, fever greater than 100.4 F for 3 days. Finally began feeling somewhat better on 3/7/23.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 2/11/21 Lot# 015M20A;  Moderna 3/11/21 Lot# 030A2  (That is the information from the database)
Age: 28.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: +COVID-was vaccinated
Age: 48.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: +COVID-Vaccinated
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Janssen 4/11/21 Lot# 207A21A;  Janssen 1/13/22 Lot# 1855835
Age: 2.0
Sex: M
Vaccine: COVID19, FLU4, HEPA
Symptoms: Product preparation issue
Clinical narrative: The single use diluent that was used to prepare the COVID vaccines was used to prepare 2 other COVID vaccines given that day.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Incorrect BUD had been written on label for vaccine and dose was given 1 day post manufacturers expiration date.  Manufacturer contacted and they performed a viability test on the lot number and determined that the dose was still viable and that there was no need to re-vaccinate.  Patient was contacted and dose entered in database as a historical dose.
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: patient received the bi-valent instead of the monovalent moderna
Age: 5.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pfizer bivalent was given as second dose instead of Pfizer monovalent.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory, Exposure to SARS-CoV-2, Heart rate irregular
Clinical narrative: Erratic heart beat (palpitations) began a few weeks after injection, especially and consistently upon lying down. HOWEVER, I was exposed to Covid one week after receiving vaccine and developed very mild symptoms a few days later, which only lasted a few days.. I did 2 home tests, but neither was conclusive. (One showed what could have been a faint line, but I wasn't sure.) I'm not sure if palpitations were caused by Covid itself or the bivalent vaccine, but my doctor seemed to think it was the vaccine because he had read about similar cases in the literature.  Palpitations continue, but much less frequently and severely, but no longer when lying down.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Palpitations, Sleep study
Clinical narrative: Erratic heart beat (palpitations) began a few weeks after injection, especially and consistently upon lying down. HOWEVER, I was exposed to Covid one week after receiving vaccine and developed very mild symptoms a few days later, which only lasted a few days.. I did 2 home tests, but neither was conclusive. (One showed what could have been a faint line, but I wasn't sure.) I'm not sure if palpitations were caused by Covid itself or the bivalent vaccine, but my doctor seemed to think it was the vaccine because he had read about similar cases in the literature.  Palpitations continue, but much less frequently and severely, but no longer when lying down.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Immediate post-injection reaction, Rash, Rash erythematous, Rash pruritic
Clinical narrative: Immediate rash on my inner arm that spread to my other arm and torso. Very patchy, red, itchy and dry - lasted for a month and is still on me today
Age: 3.0
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Expired product administered
Clinical narrative: Private vaccine lot number expired on 3/5/2023 and was administered to patient on 3/7/2023. Nurse did not pay attention to lot numbers when selecting. In the process of trying to reach mother to have her scheduled for repeat Pediarix dosage. Incident form has been completed with practice.
Age: 13.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pfizer bivalent was given as a second dose instead of the Pfizer monovalent.
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: N/A - patient given dose of bivalent Pfizer 5 days beyond use date. No adverse outcomes.
Age: 11.0
Sex: M
Vaccine: COVID19-2, HEP, HPV9, MNQ, TDAP, VARCEL
Symptoms: Product preparation issue
Clinical narrative: The single use diluent that was used to prepare the COVID vaccines was used to prepare 2 other COVID vaccines given that day.  The manufacturer was called. Based on research, there is no need for revaccination but there is a risk for bacterial infection. Pt's mother informed of error and risk and confirmed understanding. As of now, patient has not shown any signs of infection. Mother advised to call back for any further concern or question.
Age: 80.0
Sex: M
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Got COVID-was vaccinated
Age: 47.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Vaccinated, got covid
Age: 24.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Vaccinated-got covid
Age: 11.0
Sex: M
Vaccine: COVID19-2, FLU4, HEP, HPV9, MNQ, TDAP, VARCEL
Symptoms: Product preparation issue
Clinical narrative: The single use diluent that was used to prepare the COVID vaccines was used to prepare 2 other COVID vaccines given that day.  The manufacturer was called. Based on research, there is no need for revaccination but there is a risk for bacterial infection. Pt's mother informed of error and risk and confirmed understanding. As of now, patient has not shown any signs of infection. Mother advised to call back for any further concern or question.
Age: 72.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: +COVID-Vaccinated
Age: 0.33
Sex: F
Vaccine: DTPPVHBHPB
Symptoms: Extra dose administered, No adverse event, Wrong product administered
Clinical narrative: Patient ordered Pentacel and received Vaxelis.  No adverse reaction noted, just extra dose of hep b.
Age: 84.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: +covid-immunized
Age: 1.25
Sex: F
Vaccine: COVID19-2, DTAP
Symptoms: Product preparation issue
Clinical narrative: The single use diluent that was used to prepare the COVID vaccines was used to prepare 2 other COVID vaccines given that day.  The manufacturer was called. Based on research, there is no need for revaccination but there is a risk for bacterial infection. Pt's mother informed of error and risk and confirmed understanding. As of now, patient has not shown any signs of infection. Mother advised to call back for any further concern or question.
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: Presented for bivalent vaccine. Vaccine card presented after administration showed previous bivalent vaccine 9/20/2022. Denies no side effects following previous bivalent vaccine. Instructed to monitor for and report any side effects.
Age: 78.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Asthenia, COVID-19, Cough, Fatigue, Hypersomnia
Clinical narrative: 12/24/2022 I was feeling a little bit under the weather. I tested positive with a home COVID test on 12/25/2022. I was sneezing, coughing, runny nose and felt very tired. I began to sleep a lot more. I had no energy. I called the doctor on 12/26/22 and was prescribed PAXLOVID. I tested negative for COVID. After completing the PAXLOVID, I tested positive for COVID again. I was quite fatigued for around three weeks. I did not test negative again until 2 weeks and 5 days after testing positive the first time.
Age: 78.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Malaise, Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: 12/24/2022 I was feeling a little bit under the weather. I tested positive with a home COVID test on 12/25/2022. I was sneezing, coughing, runny nose and felt very tired. I began to sleep a lot more. I had no energy. I called the doctor on 12/26/22 and was prescribed PAXLOVID. I tested negative for COVID. After completing the PAXLOVID, I tested positive for COVID again. I was quite fatigued for around three weeks. I did not test negative again until 2 weeks and 5 days after testing positive the first time.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Respiratory tract congestion, Somnolence
Clinical narrative: Fatigue, Sleepy coughing Congestion
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acoustic stimulation tests, Tinnitus
Clinical narrative: I experienced increased tinnitus and went to the doctor to discuss it.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Brain fog, Fatigue, Headache, Herpes zoster, Influenza
Clinical narrative: it was my second in series of 2 shingles shot.  I became very ill the following day when I woke up in the morning-flu symptoms, sever headache, fever, fatigue, brain fog which lasted 5 days.  I then experienced a shingles outbreak on my buttocks.  I still am trying to heal the ~ 3"x3" out break area.  Skin site is very painful, red, blistery, and itchy.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site vesicles, Malaise
Clinical narrative: it was my second in series of 2 shingles shot.  I became very ill the following day when I woke up in the morning-flu symptoms, sever headache, fever, fatigue, brain fog which lasted 5 days.  I then experienced a shingles outbreak on my buttocks.  I still am trying to heal the ~ 3"x3" out break area.  Skin site is very painful, red, blistery, and itchy.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: it was my second in series of 2 shingles shot.  I became very ill the following day when I woke up in the morning-flu symptoms, sever headache, fever, fatigue, brain fog which lasted 5 days.  I then experienced a shingles outbreak on my buttocks.  I still am trying to heal the ~ 3"x3" out break area.  Skin site is very painful, red, blistery, and itchy.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Headache, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I had a bad headache and was starting to get sinus congestion and a cough. I was feeling a little feverish. I took an at home COVID-19 test and it tested positive. After that, I was able to get the telehealth appointment around 08:40 that morning. After going through the meeting with the PA, she prescribed Paxlovid for me. I started to take the Paxlovid that day around 10:00AM and took the 5 day regimen every 12 hours. After the end of the first dose before the 2nd dose, the symptoms had subsided. For the 5 days of Paxlovid, I felt a little brain fog and had a metallic taste in my mouth. I didn't feel too bad, just lousy. I quarantined by myself for 5 days. Other than those 2 symptoms from the Paxlovid, I was fine. On the 5th day, I did test again and came back negative and I've been negative since. It was a pretty mild encounter with COVID-19. Took a couple weeks to feel fully myself again between the infection and the strong medication.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Sinus congestion
Clinical narrative: I had a bad headache and was starting to get sinus congestion and a cough. I was feeling a little feverish. I took an at home COVID-19 test and it tested positive. After that, I was able to get the telehealth appointment around 08:40 that morning. After going through the meeting with the PA, she prescribed Paxlovid for me. I started to take the Paxlovid that day around 10:00AM and took the 5 day regimen every 12 hours. After the end of the first dose before the 2nd dose, the symptoms had subsided. For the 5 days of Paxlovid, I felt a little brain fog and had a metallic taste in my mouth. I didn't feel too bad, just lousy. I quarantined by myself for 5 days. Other than those 2 symptoms from the Paxlovid, I was fine. On the 5th day, I did test again and came back negative and I've been negative since. It was a pretty mild encounter with COVID-19. Took a couple weeks to feel fully myself again between the infection and the strong medication.
Age: 3.0
Sex: F
Vaccine: FLU4, HEPA, HIBV, PNC13
Symptoms: Expired product administered, No adverse event, Vaccination error
Clinical narrative: On 02/20/2023 patient received vaccine ActHIB that had expired 11/30/2022. Patient's mother informed of vaccine error by medical provider and was scheduled to come back for revaccination. Patient seen on 02/22/2023 and revaccinated with vaccine (not expired).  Lot: UJ636AAA, IM on RD. Exp:02/26/2023. Patient did not report any adverse signs or symptoms.
Age: 12.0
Sex: F
Vaccine: DTAP
Symptoms: Medication error, Wrong product administered
Clinical narrative: Pt was given the DTap instead of the TDap in error.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Cough, Dizziness, Dyspnoea
Clinical narrative: 5/30/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 6/8/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 6/18/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 6/23/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 7/7/22 Emergency Room - heavy cough with lower back pain, shallow breath, sharp chest pain 11/19/22 feverish, heavy fatigue, headache, nausea, numbness in hands and feet, winded with motion 12/12/22 Emergency Room- not seen after 13hr wait - chest pain and trouble breathing, weak 1/19/23 Emergency Room - dizzy in the morning, numbness in hands and feet, dizzy, nausea, headache 3/7/23 Emergency Room - diarrhea, dizziness, numbness in hands and feet, almost lost consciousness, shivering, feeling very cold, palpitations
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold, Headache, Hypoaesthesia, Nausea
Clinical narrative: 5/30/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 6/8/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 6/18/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 6/23/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 7/7/22 Emergency Room - heavy cough with lower back pain, shallow breath, sharp chest pain 11/19/22 feverish, heavy fatigue, headache, nausea, numbness in hands and feet, winded with motion 12/12/22 Emergency Room- not seen after 13hr wait - chest pain and trouble breathing, weak 1/19/23 Emergency Room - dizzy in the morning, numbness in hands and feet, dizzy, nausea, headache 3/7/23 Emergency Room - diarrhea, dizziness, numbness in hands and feet, almost lost consciousness, shivering, feeling very cold, palpitations
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations, Pyrexia
Clinical narrative: 5/30/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 6/8/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 6/18/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 6/23/22 feverish, heavy fatigue, headache, nausea, cough, dry air pipe 7/7/22 Emergency Room - heavy cough with lower back pain, shallow breath, sharp chest pain 11/19/22 feverish, heavy fatigue, headache, nausea, numbness in hands and feet, winded with motion 12/12/22 Emergency Room- not seen after 13hr wait - chest pain and trouble breathing, weak 1/19/23 Emergency Room - dizzy in the morning, numbness in hands and feet, dizzy, nausea, headache 3/7/23 Emergency Room - diarrhea, dizziness, numbness in hands and feet, almost lost consciousness, shivering, feeling very cold, palpitations
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: post-mortem PCR result for COVID was probable; pt passed away in his home.
Age: 48.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pfizer Bivalent was administered as the 1st primary dose.
Age: 0.58
Sex: M
Vaccine: RV1
Symptoms: Extra dose administered
Clinical narrative: Patient received 3rd dose in error
Age: 37.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given Pfizer Bivalent for 1st dose in primary series.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test abnormal, Dizziness, Fatigue, Palpitations, Rash
Clinical narrative: My husband has a severe rash all over his body. It's mainly in his hair, neck, shoulder, back, and legs. He is constantly scratching. That's his biggest compliant. He is tired a lot. Heart pounding and racing. He gets dizzy. He's lost weight (30 lbs).  It's getting worse.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Scratch, Weight decreased, White blood cell count increased
Clinical narrative: My husband has a severe rash all over his body. It's mainly in his hair, neck, shoulder, back, and legs. He is constantly scratching. That's his biggest compliant. He is tired a lot. Heart pounding and racing. He gets dizzy. He's lost weight (30 lbs).  It's getting worse.
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site pain
Clinical narrative: Patient developed pain in the deltoid muscle after the vaccination. Pain persistent as of date of this report (3/8). No findings on exam.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Chills, Cough, Exercise tolerance decreased
Clinical narrative: After receiving my 5th dose of Moderna I contacted COVID-19 infection. My COVID-19 infection started on 01/23/2023 not sure what time of the day. I was sneezing, had a runny nose, fever, chills, fatigue, cough, and body aches. My energy levels became very slow. I tested with a home COVID-19 test on 01/26/2023  which was positive. I did a telehealth with a doctor on the same day and he prescribed me with PAXLOVID for 5 days. After 3 days of finishing the PAXLOVID I had a relapse on 02/02/2023. I had same symptoms except fever. We took over the counter medications such as TYLENOL and other cold medications. After COVID-19 infection my energy level and exercise tolerance is not the same.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: After receiving my 5th dose of Moderna I contacted COVID-19 infection. My COVID-19 infection started on 01/23/2023 not sure what time of the day. I was sneezing, had a runny nose, fever, chills, fatigue, cough, and body aches. My energy levels became very slow. I tested with a home COVID-19 test on 01/26/2023  which was positive. I did a telehealth with a doctor on the same day and he prescribed me with PAXLOVID for 5 days. After 3 days of finishing the PAXLOVID I had a relapse on 02/02/2023. I had same symptoms except fever. We took over the counter medications such as TYLENOL and other cold medications. After COVID-19 infection my energy level and exercise tolerance is not the same.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sneezing
Clinical narrative: After receiving my 5th dose of Moderna I contacted COVID-19 infection. My COVID-19 infection started on 01/23/2023 not sure what time of the day. I was sneezing, had a runny nose, fever, chills, fatigue, cough, and body aches. My energy levels became very slow. I tested with a home COVID-19 test on 01/26/2023  which was positive. I did a telehealth with a doctor on the same day and he prescribed me with PAXLOVID for 5 days. After 3 days of finishing the PAXLOVID I had a relapse on 02/02/2023. I had same symptoms except fever. We took over the counter medications such as TYLENOL and other cold medications. After COVID-19 infection my energy level and exercise tolerance is not the same.
Age: 64.0
Sex: F
Vaccine: TDAP
Symptoms: Joint noise, Pain, Vaccination site movement impairment
Clinical narrative: The client is experiencing pain, popping, and the inability to move her right shoulder 1 week post vaccination.
Age: 76.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Peripheral swelling, Vaccination site rash
Clinical narrative: pts right arm had swelling, and a rash to the vaccine site. pt was seen by pcp on 3/8/2023 and was given and antibiotic and steroids, for possible allergic reaction, and infection.
Age: 39.0
Sex: M
Vaccine: DTAPIPV
Symptoms: No adverse event, Skin laceration, Wrong product administered
Clinical narrative: Patient presented to our clinic for a laceration.  Provider ordered patient to get a TDAP.  Patient was accidentally given a Kinrix instead of a Boostrix.  No adverse reactions noted.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Brain fog, Full blood count, Hypoaesthesia, Thyroid function test, Vitamin D
Clinical narrative: Bilateral hand numbness, Brain fog
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count
Clinical narrative: Bilateral hand numbness, Brain fog
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: pt received unknown vaccine. by error bivalent was given instead of monovalent.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cardiac function test, Chest discomfort, Chest pain, Lethargy
Clinical narrative: Tightness and pain across the chest, extreme lethargy and lack of energy.  Went from running 127 miles in an ultra marathon in March, 21 to barely being able to climb a set of stairs in October, 21.